The long-running dispute between the USA and Brazil, which included imposing sanctions on US imports of pharmaceutical products, among total sanctions of $591 million (The Pharma Letter April 8), has moved a further step forward.
The Brazilian Foreign Board (CAMEX) - the agency that encompasses the ministers entitled to tailor the foreign trade policy - met last week and approved an agreement with the USA, which suspended until 2012 the applicability of commercial sanctions against the US subsidies to cotton producers, noted a blogger on IP Tango.
Both governments will sign a Memorandum of Understanding to establish a new set of negotiations, consultations and reforms until the US government finalize the elaboration of a new agricultural law by 2012.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze